At a glance
ClinicalIndex Comparison RecordN/ACompleted· 372 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Altered Faecal Microbiome and Metabolome in Childhood-onset Type 1 Diabetes, Adult-onset Type 1 Diabetes and Type 2 Diabetes
Second Xiangya Hospital of Central South University·observational·Posted Feb 23, 2022·Updated Jul 11, 2023
In Brief
An observational study for Type 1 Diabetes Mellitus Maturity Onset. Completed, enrolled 372 participants across 1 site.
Detailed Summary
To elucidate the characteristics of global gut microbiota and fecal/serum metabolites in patients with childhood-onset type 1 diabetes, adult-onset type 1 diabetes or type 2 diabetes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus Maturity Onset
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartFeb 2019
First PostedFeb 2022
Primary CompletionApr 2022
TodayJul 2026
First PostedFeb 23, 2022
Enrollment StartFeb 1, 2019
Primary CompletionApr 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 4.4 years ago